Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way?The Motley Fool • 08/20/26
Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here's Why TLRY Is Still Down 47% YTD24/7 Wall Street • 08/19/26
Aurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis MarketPRNewsWire • 08/19/26
AURORA CANNABIS INC. URGES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPECT TO THE UNSOLICITED TAKE-OVER BID BY CURALEAF HOLDINGS, INC.PRNewsWire • 08/19/26
Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target?The Motley Fool • 08/16/26
Should You Buy ACB Stock Amid Curaleaf's Hostile Takeover Attempt?Zacks Investment Research • 08/12/26
Curaleaf Just Announced a Hostile Takeover Bid for Aurora Cannabis. Here's What This Means for Investors.The Motley Fool • 08/12/26
Curaleaf Announces Intention to Launch Take-Over Bid for Aurora Cannabis to Solidify its Position as the Global Cannabis Industry LeaderPRNewsWire • 08/11/26
Aurora, a Global Leader in Medical Cannabis, Announces Results of 2026 Annual General MeetingPRNewsWire • 08/10/26
Aurora Cannabis Inc. (ACB) Q1 Earnings and Revenues Beat EstimatesZacks Investment Research • 08/05/26
Aurora Receives Support from Leading Independent Proxy Adviser Institutional Shareholder Services Inc. for the 2026 Annual General Meeting of ShareholdersPRNewsWire • 07/27/26
Safari Flower Company, a Wholly Owned Subsidiary of Aurora Cannabis, Receives EU-GMP Certification at Niagara FacilityPRNewsWire • 07/23/26